Lupin Limited has informed the Exchange regarding a press release dated August 10, 2026, titled "Lupin Announces the Approval of Sodium Zirconium Cyclosilicate for Oral Suspensionin the United States ".
Lupin Limited Press Release Aug 10 2026
Filed with NSE · · 2 pages · English
Release
Earlier from Lupin
- Lupin Limited Press Release Aug 06 2026
- Lupin Limited Press Release Jul 31 2026
- Lupin Announces U.S. FDA Approval and Launch of Sugammadex Injection
- Lupin Limited Press Release Jul 14 2026
- Lupin Named Among World's Most Sustainable Companies by TIME and Statista
Later from Lupin
- Lupin Limited Press Release Aug 17 2026
- Lupin Announces Approval from U.S. FDA for Pitolisant Tablets
- Lupin and Tenpoint Therapeutics Announce Strategic Partnership to Commercialize YUVEZZI™ in the European Union, the United Kingdom, Switzerland, Norway, and Iceland
- Lupin Receives U.S. FDA Approval for Modafinil Tablets, USP
- Lupin Limited Press Release Sep 28 2026
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin